Gómez-Barrena Enrique, Ehrnthaller Christian
Department of Orthopaedic Surgery and Traumatology, Hospital La Paz-IdiPaz, Universidad Autónoma de Madrid, Madrid, Spain.
Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich, Germany.
EFORT Open Rev. 2024 May 10;9(5):329-338. doi: 10.1530/EOR-24-0032.
Long bone non-unions represent a serious clinical and socioeconomical problem due to the prolonged episodes, frequent sequelae, and variable treatment effectiveness. Bone grafts, classically involving the autologous iliac crest graft as the 'gold standard' bone graft, enhance bone regeneration and fracture healing incorporating osteoconductive and/or osteoinductive/osteogenic capacity to the non-union under treatment. Structural alternatives to autologous bone grafts include allografts and bone substitutes, expanding the available stock but loosing biological properties associated with cells in the graft. Biological alternatives to autologous bone grafts include bone marrow concentration from iliac crest aspiration, bone marrow aspiration from reaming of the diaphyseal medullary canal in the long bones, and isolated, expanded mesenchymal stem cells under investigation. When the combination with natural and synthetic bone substitutes allows for larger volumes of structural grafts, the enhancement of the biological regenerative properties through the incorporation of cells and their secretoma permits to foresee new bone grafting solutions and techniques.
由于病程延长、后遗症频繁以及治疗效果不一,长骨不愈合是一个严重的临床和社会经济问题。传统上,骨移植以自体髂嵴移植作为“金标准”骨移植,通过赋予治疗中的不愈合部位骨传导性和/或骨诱导/成骨能力,增强骨再生和骨折愈合。自体骨移植的结构替代物包括同种异体骨和骨替代物,增加了可用储备,但丧失了与移植骨中细胞相关的生物学特性。自体骨移植的生物学替代物包括髂嵴穿刺获得的骨髓浓缩物、长骨干骺端髓腔扩髓获得的骨髓抽吸物以及正在研究的分离、扩增的间充质干细胞。当与天然和合成骨替代物联合使用可提供更大体积的结构性移植骨时,通过加入细胞及其分泌物增强生物学再生特性,有望带来新的骨移植解决方案和技术。